Johnson & Johnson has just received approval from the FDA for emergency use of their COVID-19 vaccine, making it the 3rd vaccine, and the first typical “viral vector” vaccine to treat COVID here in the United States. Johnson & Johnson joins Astrazeneca as a more traditional alternative to the Moderna and Pfizer mRNA vaccines approved […]
All of us will soon be making a decision on whether we will be receiving one of the new COVID-19 vaccines. The goal of NCER is to provide knowledge and understanding of these vaccines, which will give us power to make ethical choices, giving us peace of mind and heart for ourselves and our families. […]
NCER Comments: Remdesivir is an antiviral drug developed and produced using ethical means. However, results have been weak in preventing both hospitalizations and death. Additionally, itʼs cost is exorbitant at $1,000 per treatment. What about the highly anticipated therapy known as Remdesivir? Is it an ethical and effective option in beating COVID-19? An excerpt from a recently published [&...
NCER Comments: As part of an NIH randomized, placebo-controlled clinical trial, UNMC is currently studying the effects of the antiviral drug Remdesivir on COVID-19 patients. Outcomes seen as quickly as within 15 days are being monitored by a national independent safety board, and the unofficial results are positive so far. The UNMC “Quarantine Unit” (in […]